Bellatrix Announces Executive Management Changes

CALGARY, Alberta, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Bellatrix Exploration Ltd. (“Bellatrix” or the “Company”) (TSX: BXE) announces that Mr. Maxwell Lof will be resigning from his position as the Company’s Executive Vice President & Chief Financial Officer, effective August 31, 2019, to focus on ongoing health issues. 

Bellatrix also announces the hiring and appointment of Mr. Shane Abel as the Company’s new Executive Vice President & Chief Financial Officer, effective September 1, 2019.  Mr. Abel has over eight years of financial executive experience at both public and private companies, and was most recently the Chief Financial Officer of High Ground Energy Inc., a Calgary-based, private equity sponsored oil and gas producer. Mr. Abel’s background also includes almost a decade of experience as an investment banker with BMO Capital Markets, including mergers & acquisitions, equities, debt securities, and bank facilities.

Brent Eshleman, the Company’s President & Chief Executive Officer, commented “while we are sad to see Max leave us, we support him in his decision and wish him good health. We are very pleased to add Shane to the executive management team, and believe that his background and experience will be a great addition for Bellatrix.”

Bellatrix Exploration Ltd. is a publicly traded Western Canadian based growth oriented oil and gas company engaged in the exploration for, and the acquisition, development and production of oil and natural gas reserves, with highly concentrated operations in west central Alberta, principally focused on profitable development of the Spirit River liquids rich natural gas play. 

For further information, please contact:

Steve Toth, CFA, Vice President, Investor Relations & Corporate Development (403) 750-1270

Bellatrix Exploration Ltd.
1920, 800 – 5^th Avenue SW
Calgary, Alberta, Canada T2P 3T6
Phone: (403) 266-8670
Fax: (403) 264-8163
www.bxe.com

You May Also Be Interested In

• AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
• Borealis Foods CEO Highlights Manufacturing Partnerships with Leading Global Food Companies as New Product Rollout Expands in U.S. and Canada
• Ticombo Releases World Cup 2026 Final Ticket Availability Report